Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Combination Therapies to Reduce the Nasopharyngeal Carriage of SARS-CoV-2 and Improve the Outcome of COVID-19 Infection in Ivory Coast (INTENSE-COV): a Phase IIb Randomized Clinical Trial

NCT04466241 is registered in ClinicalTrials.gov with ANRS, Emerging Infectious Diseases as lead sponsor.

NCT NCT04466241
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04466241 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Combination Therapies to Reduce the Nasopharyngeal Carriage of SARS-CoV-2 and Improve the Outcome of COVID-19 Infection in Ivory Coast (INTENSE-COV): a Phase IIb Randomized Clinical Trial
Lead sponsor
ANRS, Emerging Infectious Diseases
Phase
Phase 2/3
Overall status
Completed
Start date
November 27, 2020
Completion date
November 1, 2021
Enrollment
294 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19, covid-19 drug treatment, severe acute respiratory syndrome coronavirus 2